In this review, we summarize the literatures on the role of the Apelin–APJ system in diabetes and obesity for a better understanding of the mechanism and function of apelin and its receptor in the pathophysiology of diseases that may contribute to the development of new therapies. This evidence concerns the gene APLN and obesity due to melanocortin 4 receptor deficiency.